558 related articles for article (PubMed ID: 11326645)
1. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
2. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
3. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
Körner H; Söreide K; Stokkeland PJ; Söreide JA
Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
[TBL] [Abstract][Full Text] [Related]
5. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.
Bruns F; Micke O; Halek G; Schäfer U; Willich N
Anticancer Res; 2003; 23(2A):1103-6. PubMed ID: 12820355
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
8. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
9. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
[TBL] [Abstract][Full Text] [Related]
10. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
[TBL] [Abstract][Full Text] [Related]
13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
14. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
Wolf RF; Cohen AM
J Am Coll Surg; 1997 Jul; 185(1):60-4. PubMed ID: 9208962
[TBL] [Abstract][Full Text] [Related]
15. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
16. [The value of tumor markers in colorectal cancer].
Peters KM; Grundmann R
Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers in patients with relapse of colorectal carcinoma.
Lipská L; Visokai V; Levý M; Svobodová S; Kormunda S; Fínek J
Anticancer Res; 2007; 27(4A):1901-5. PubMed ID: 17649792
[TBL] [Abstract][Full Text] [Related]
19. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
[TBL] [Abstract][Full Text] [Related]
20. Value of follow-up in the management of recurrent colorectal cancer.
Camuñas J; Enriquez JM; Devesa JM; Morales V; Millan I
Eur J Surg Oncol; 1991 Oct; 17(5):530-5. PubMed ID: 1936302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
